Mirae Asset Global Etfs Holdings Ltd. Procept Bio Robotics Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 683,733 shares of PRCT stock, worth $67.7 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
683,733Holding current value
$67.7 Million% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
234Shares Held
36.6MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$467 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$345 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$179 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$173 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$135 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.42B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...